Each method has its unique set of benefits, driven by factors such as bioavailability, convenience, cost, and personal health goals
were the first to reveal the negative association between the expression of miR-199a-3p and mTOR, c-Met and Stat3 (Duan et al., 2015)
5.6 Personalized medicine and holistic approaches The increasing knowledge of the gut-brain-kidney axis offers the potential for personalized treatments, especially in CKD patients
Increased gastric PGE2 biosynthesis in cirrhotic patients with gastric vascular ectasia
Since glutamate is one of the brains major excitatory neurotransmitters, this pathway has drawn interest in conditions such as obsessive-compulsive disorder (OCD), depression, bipolar disorder, and substance use disorders.11 29 The evidence is still uneven